Predicting translational progress in biomedical research

被引:62
作者
Hutchins, B. Ian [1 ]
Davis, Matthew T. [1 ]
Meseroll, Rebecca A. [1 ]
Santangelo, George M. [1 ]
机构
[1] NIH, Off Portfolio Anal, Div Program Coordinat Planning & Strateg Initiat, Bldg 10, Bethesda, MD 20892 USA
关键词
INNOVATION; SUPPORT;
D O I
10.1371/journal.pbio.3000416
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fundamental scientific advances can take decades to translate into improvements in human health. Shortening this interval would increase the rate at which scientific discoveries lead to successful treatment of human disease. One way to accomplish this would be to identify which advances in knowledge are most likely to translate into clinical research. Toward that end, we built a machine learning system that detects whether a paper is likely to be cited by a future clinical trial or guideline. Despite the noisiness of citation dynamics, as little as 2 years of postpublication data yield accurate predictions about a paper's eventual citation by a clinical article (accuracy = 84%, F1 score = 0.56; compared to 19% accuracy by chance). We found that distinct knowledge flow trajectories are linked to papers that either succeed or fail to influence clinical research. Translational progress in biomedicine can therefore be assessed and predicted in real time based on information conveyed by the scientific community's early reaction to a paper.
引用
收藏
页数:25
相关论文
共 41 条
[1]  
[Anonymous], 2011, J. Mach. Learn. Technol
[2]  
Archer S, 2017, DAUNTING ENTERPRISE OF THE LAW: ESSAYS IN HONOUR OF HARRY W. ARTHURS, P3
[3]   Landscape of Innovation for Cardiovascular Pharmaceuticals: From Basic Science to New Molecular Entities [J].
Beierlein, Jennifer M. ;
McNamee, Laura M. ;
Walsh, Michaell J. ;
Kaitin, Kenneth I. ;
DiMasi, Joseph A. ;
Ledley, Fred D. .
CLINICAL THERAPEUTICS, 2017, 39 (07) :1409-1425
[4]   Patterns of Innovation in Alzheimer's Disease Drug Development: A Strategic Assessment Based on Technological Maturity [J].
Beierlein, Jennifer M. ;
McNamee, Laura M. ;
Walsh, Michael J. ;
Ledley, Fred D. .
CLINICAL THERAPEUTICS, 2015, 37 (08) :1643-1651
[5]   No shortcuts for research assessment [J].
Bertuzzi, Stefano ;
Drubin, David G. .
MOLECULAR BIOLOGY OF THE CELL, 2013, 24 (10) :1505-1506
[6]   Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[7]  
Bush Vannevar., 1945, Science Education Sci. Ed, V29, P218
[8]   Contribution of NIH funding to new drug approvals 2010-2016 [J].
Cleary, Ekaterina Galkina ;
Beierlein, Jennifer M. ;
Khanuja, Navleen Surjit ;
McNamee, Laura M. ;
Ledley, Fred D. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (10) :2329-2334
[9]   Innovation in Therapeutics Development at the NCATS [J].
Colvis, Christine M. ;
Austin, Christopher P. .
NEUROPSYCHOPHARMACOLOGY, 2014, 39 (01) :230-232
[10]   Medicine - Life cycle of translational research for medical interventions [J].
Contopoulos-Ioannidis, Despina G. ;
Alexiou, George A. ;
Gouvias, Theodore C. ;
Ioannidis, John P. A. .
SCIENCE, 2008, 321 (5894) :1298-1299